Midas Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Midas Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-250	Closed	-$13K	–	144
2017 Q4	$13K	Hold	250	–	–	0.01%	136
2017 Q3	$14K	Hold	250	–	–	0.01%	121
2017 Q2	$15K	Hold	250	–	–	0.01%	124
2017 Q1	$14K	Buy	+250	New	+$12.3K	0.01%	136

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Midas Management's BIVV Position: Q1 2018 in Review

Midas Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 250 shares — an estimated $13K sold.

Midas Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $15K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Midas Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Midas Management sold 250 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $13K.
Midas Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Midas Management's Bioverativ Inc. Common Stock position peaked at $15K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Midas Management's 13F filing for Q1 2018, filed 16 Apr 2018.